Sheri Tarr is the Founder and Chief advisor of ‘68PARTNERS, a consulting firm dedicated to helping life sciences stakeholders and cannabis companies build sustainable brands and businesses that have a transformative impact on consumers and patients. Sheri is a commercialization, compliance, and regulatory expert with extensive experience in the pharmaceutical sector, and the emerging cannabis and hemp industries. She first held leadership positions in sales and marketing with global responsibility in Fortune 500 pharmaceutical and medical device companies. Then Sheri became an attorney who spent her career in the courtroom holding pharmaceutical companies and medical device manufacturers accountable for deceptive marketing practices and defective manufacturing.
Sheri has amassed over three decades of real-world experience operating in a highly-regulated environment — from concept to consumer to exit — and a deep understanding of the complex organizational, business, and regulatory challenges faced by stakeholders. As a pharmaceutical executive-turned litigator, Sheri understands the tension between risk and profit– and how to strike the right balance. Using her deep business and legal know-how, Sheri works with clients to develop practical commercialization strategies and regulatory pathways that balance financial objectives with foreseeable risk.
Sheri’s specialties include straight-talk and practical advice; commercialization planning and strategies; regulatory guidance; cannabis licensing applications consulting; risk mitigation and best compliance practices; review of promotional materials, packaging and labeling; brand analysis and product launch strategies; partnership development, and advocacy before regulators, adjudicators, investors and critical audiences. Over the course of her expansive career, Sheri’s work has involved products that cover the spectrum of life sciences, including CBD- and hemp-derived products from topicals to tinctures to food; medical devices; clinical laboratory testing kits and equipment; pharmaceuticals; cancer diagnostics and therapeutics; personalized medicine; biomarker technologies; SaaS sales training systems, and beyond. Her clients include emerging and mid- to small-cap companies, cannabis license-holders and applicants, C-suites, investors, law firms and other service providers.
A University of Michigan alum and Illinois Institute of Technology-Chicago-Kent College of Law graduate, Sheri serves as Director and Regulatory Committee Co-Chair of NYC Cannabis Industry Association, is a sought after speaker, and is long-time voting rights advocate.